CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 186 filers reported holding CHEMOCENTRYX INC in Q2 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $163,000 | +19.0% | 3,130 | -43.3% | 0.00% | – |
| Q2 2022 | $137,000 | -35.4% | 5,520 | -15.9% | 0.00% | – |
| Q1 2022 | $212,000 | -68.8% | 6,560 | -64.9% | 0.00% | -100.0% |
| Q4 2021 | $680,000 | +623.4% | 18,677 | +242.0% | 0.00% | – |
| Q3 2021 | $94,000 | +6.8% | 5,461 | -17.6% | 0.00% | – |
| Q2 2021 | $88,000 | +95.6% | 6,625 | +667.7% | 0.00% | – |
| Q1 2021 | $45,000 | -13.5% | 863 | +0.9% | 0.00% | – |
| Q4 2020 | $52,000 | +940.0% | 855 | +860.7% | 0.00% | – |
| Q3 2020 | $5,000 | -89.4% | 89 | -92.3% | 0.00% | – |
| Q1 2020 | $47,000 | – | 1,161 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |